Moreover, novel interactions between tumor-secreted IGFBP-7 and CD93 on endothelial cells led to reduced angiogenesis and slowed tumor growth in in vitro models of melanoma, confirming the role of IGFBP-7:CD93 interactions in tumor development [76]. This evidence concerns the gene CD93 and neoplasm.